Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein

Cancer Science

Volumn 102, Issue 1, 2011, Pages 36-43

  Hatakeyama, Masanori ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CAGA PROTEIN; ONCOPROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTHROPOLOGY; BACTERIAL VIRULENCE; CARBOXY TERMINAL SEQUENCE; CARCINOGENIC ACTIVITY; EPITHELIUM CELL; GEOGRAPHICAL VARIATION (SPECIES); HELICOBACTER PYLORI; HOST CELL; HUMAN; MITOGENICITY; MOLECULAR PHYLOGENY; NONHUMAN; PATHOPHYSIOLOGY; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN MULTIMERIZATION; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SOUTHEAST ASIA; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STRUCTURE ACTIVITY RELATION;

AMINO ACID MOTIFS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; HUMANS; PROTEIN MULTIMERIZATION; REPETITIVE SEQUENCES, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78650196039     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01743.x     Document Type: Review

References (78)

1. Parkin DM. International variation. Oncogene 2004; 23: 6329-40.
2. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
3. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 28-37.
4. Covacci A, Censini S, Bugnoli M et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5.
5. Hatakeyama M. Oncogenic mechanisms of Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4: 688-94.
6. Hatakeyama M. SagA of CagA in Helicobacter pylori pathogenesis. Curr Opin Microbiol 2008; 11: 30-7.
7. Censini S, Lange C, Xiang Z et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-53.
8. Pitzschke A, Hirt H. New insights into an old story: Agrobacterium-induced tumour in plants by plant transformation. EMBO J 2010; 29: 1021-32.
9. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 1999; 96: 14559-64.
10. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287: 1497-500.
11. Asahi M, Azuma T, Ito S et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000; 191: 593-602.
12. Backert S, Ziska E, Brinkmann V et al. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol 2000; 2: 155-64.
13. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-drive host cell translocation. Proc Natl Acad Sci USA 2000; 97: 1263-8.
14. Kwok T, Zabler D, Urman S et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 2007; 449: 862-6.
15. Jimenes-Soto LF, Kutter S, Sewald X et al. Helicobacter pylori type IV secretion apparatus exploits β1 integrin in a novel RGD-independent manner. PLoS Pathog 2009; 12: e1000684.
16. Murata-Kamiya N, Kikuchi K, Hayashi T, Higashi H, Hatakeyama M. Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 2010; 7: 399-411.
17. Ohnishi N, Yuasa H, Tanaka S et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 2008; 105: 1003-8.
18. Miura M, Ohnishi N, Tanaka S, Yanagiya K, Hatakeyama M. Differential oncogenic potential of geographically distinct Helicobacter pylori CagA isoforms in mice. Int J Cancer 2009; 125: 2497-504.
19. Backert S, Selbach M. Tyrosine-phosphorylated bacterial effector proteins: the enemies within. Trends Microbiol 2005; 13: 476-84.
20. Higashi H, Tsutsumi R, Muto S et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683-6.
21. Higashi H, Tsutsumi R, Fujita A et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA 2002; 99: 14428-33.
22. Higashi H, Yokoyama K, Fujii Y et al. EPIYA motif is a membrane targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem 2005; 280: 23130-7.
23. Xia Y, Yamaoka Y, Zho Q, Gao X. A comprehensive sequence and disease correlation analysis for the C-terminal region of CagA protein of Helicobacter pylori. PLoS ONE 2009; 4: e7736.
24. Naito M, Yamazaki T, Tsutsumi R et al. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 2006; 130: 1181-90.
25. Bagnoli F, Tompkins L, Covacci A, Amieva MR. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci USA 2005; 102: 16339-44.
26. Hohfeld S, Pattis I, Puls J, Plano GV, Haas R, Fischer W. A C-terminal translocation signal is necessary, but not sufficient for type IV secretion of the Helicobacter pylori CagA protein. Mol Microbiol 2006; 59: 1624-37.
27. Couturier MR, Tasca E, Montecucco C, Stein M. Interaction with CagF is required for translocation of CagA into the host via the Helicobacter pylori type IV secretion system. Infect Immun 2006; 74: 273-81.
28. Pattis I, Weiss E, Laugks R, Haas R, Fischer W. The Helicobacter pylori CagF protein is a type IV secretion chaperone-like molecule that binds close to the C-terminal secretion signal of the CagA effector protein. Microbiology 2007; 153: 2896-909.
29. Chan G, Kalaitzidis D, Neel BG. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev 2008; 27: 179-92.
30. Miyamoto D, Miyamoto M, Takahashi A et al. Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors. Oncogene 2008; 27: 3508-15.
31. Hatakeyama M, Higashi H. Helicobacter pylori CagA - a new paradigm for bacterial carcinogenesis. Cancer Sci 2005; 96: 835-43.
32. Matozaki T, Murata Y, Saito Y, Okazawa H, Ohnishi H. Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation. Cancer Sci 2009; 100: 1786-93.
33. Higashi H, Nakaya A, Tsutsumi R et al. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 2004; 279: 17205-16.
34. Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M. FAK is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol 2006; 26: 261-76.
35. Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M. Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J Biol Chem 2003; 278: 3664-70.
36. Selbach M, Paul FE, Guye P et al. Host cell interactome of tyrosine-phosphorylated bacterial proteins. Cell Host Microbe 2009; 5: 397-403.
37. Backert S, Tegtmeyer N, Selbach M. The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter 2010; 15: 163-76.
38. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, Sasakawa C. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol Cell 2002; 10: 745-55.
39. Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelia; cell adhesion. J Exp Med 2005; 202: 1235-47.
40. Ren S, Higashi H, Lu H, Azuma T, Hatakeyama M. Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J Biol Chem 2006; 281: 32344-52.
41. Saadat I, Higashi H, Obuse C et al. Helicobacter pylori CagA targets PAR-1/MARK kinase to disrupt epithelial cell polarity. Nature 2007; 447: 330-3.
42. Goldstein B, Macara IG. The PAR proteins: fundamental players in animal cell polarization. Dev Cell 2007; 13: 609-22.
43. Lu H, Saito Y, Umeda M et al. Structural and functional diversity in the PAR1b/MARK2-binding region of Helicobacter pylori CagA. Cancer Sci 2008; 99: 2004-11.
44. Lu H, Murata-Kamiya N, Saito Y, Hatakeyama M. Role of partitioning-defective 1/microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA. J Biol Chem 2009; 284: 23024-36.
45. Hatakeyama M. Linking epithelial polarity and carcinogenesis by multitasking Helicobacter pylori virulence factor CagA. Oncogene 2008; 27: 7047-54.
46. Nesic D, Miller MC, Quinkert ZT, Stein M, Chait BT, Stebbins CE. Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat Struct Mol Biol 2010; 17: 130-2.
47. Saito Y, Murata-Kamiya N, Hirayama T, Ohba Y, Hatakeyama M. Conversion of Helicobacter pylori CagA from senescence inducer to oncogenic driver through polarity-dependent regulation of p21. J Exp Med 2010; 201: 2154-74.
48. Umeda M, Murata-Kamiya N, Saito Y, Ohba Y, Takahashi M, Hatakeyama M. Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability. J Biol Chem 2009; 284: 22166-72.
49. Murata-Kamiya N, Kurashima Y, Teishikata Y et al. Helicobacter pylori CagA associates with E-cadherin and deregulates β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007; 26: 4617-26.
50. Kurashima Y, Murata-Kamiya N, Kikuchi K et al. Deregulation of β-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int J Cancer 2008; 122: 823-31.
51. Oliveira MJ, Costa AM, Costa AC et al. CagA associates with c-Met, E-cadherin, and p210-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype. J Infect Dis 2009; 200: 745-55.
52. Suzuki M, Mimuro H, Kiga K et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 2009; 5: 23-34.
53. Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, Naumann M. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 2003; 161: 249-55.
54. Snider JL, Cardeli JA. Helicobacter pylori induces cancer cell motility independent of the c-Met receptor. J Carcinog 2009; 8: 7.
55. Reyes-Leon A, Atherton JC, Argent RH, Puente JL, Torres J. Heterogeneity in the activity of Mexican Helicobacter pylori strains in gastric epithelial cells and its association with diversity in the cagA gene. Infect Immun 2007; 75: 3345-54.
56. Azuma T, Yamakawa A, Yamazaki S et al. Distinct diversity of the cag pathogenicity island among Helicobacter pylori strains in Japan. J Clin Microbiol 2004; 42: 2508-17.
57. Sicinschi LA, Corea P, Peek RM et al. CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect 2010; 16: 369-78.
58. Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter 2004; 5: 453-9.
59. Truong BX, Mai VTC, Tanaka H et al. Diverse characterization of the cagA gene of Helicobacter pylori strains in gastric cancer and peptic ulcer patients from Southern Vietnam. J Clin Microbiol 2009; 47: 4021-8.
60. Schmidt HM, Goh KL, Fock KM et al. Distinct cagA EPIYA motifs are associated with ethnic diversity in Malaysia and Singapore. Helicobacter 2009; 14: 256-63.
61. Cortes MC, Yamakawa A, Casingal CR et al. Diversity of the cagA gene of Helicobacter pylori strains from patients with gastroduodenal diseases in the Philippines. FEMS Immuno Med Microbiol 2010; 60: 90-7.
62. Tokudome S, Samsuria Soeripto WD, Triningsih FX et al. Helicobacter pylori infection appears essential for stomach carcinogenesis: observations in Semarang, Indonesia. Cancer Sci 2005; 96: 873-5.
63. Goh KL, Parasakthi N. The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country. Eur J Gastroenterol Hepatol 2001; 13: 177-83.
64. Graham DY, Yamaoka Y, Malaty HM. Thoughts about populations with unexpected low prevalences of Helicobacter pylori infection. Trans R Soc Trop Med Hyg 2007; 101: 849-51.
65. Azuma T, Yamazaki S, Yamakawa A et al. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis 2004; 189: 820-7.
66. Satomi S, Yamakawa A, Matsunaga S et al. Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. J Gastroenterol 2006; 41: 668-73.
67. Ishida T, Hinuma Y. The origin of Japanese HTLV-I. Nature 1986; 322: 504.
68. Matsumoto S, Yamasaki K, Tsuji K, Shirahama S. Human T lymphotropic virus type 1 infection and gastric cancer development in Japan. J Infect Dis 2008; 98: 10-5.
69. Ghose C, Perez-Perez GI, Dominguez-Bello MG, Prode DT, Bravi CM, Blaser MJ. East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence for its ancient human carriage. Proc Natl Acad Sci USA 2002; 99: 15107-11.
70. Yamaoka Y, Orito E, Mizokami M et al. Helicobacter pylori in North and South America before Columbus. FEBS Lett 2002; 517: 180-4.
71. Devi SM, Ahmed I, Khan AA et al. Genomes of Helicobacter pylori from native Peruvians suggest admixture of ancestral and modern lineages and reveal a western type cag-pathogenicity island. BMC Genomics 2006; 7: 191.
72. Nguyen LT, Uchida T, Murakami K, Fujioka T, Moriyama M. Helicobacter pylori and the diversity of gastric cancer in Asia. J Med Microbiol 2008; 57: 1445-53.
73. Jones KR, Joo YM, Jang S et al. Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J Clin Microbiol 2009; 47: 959-68.
74. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004; 127: 514-23.
75. Basso D, Zambon C-F, Letley DP et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008; 135: 91-9.
76. Kato S, Tsukamoto T, Mizoshita T et al. High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int J Cancer 2006; 119: 1558-66.
77. Linz B, Balloux F, Moodley Y et al. An African origin for the intimate association between human and Helicobacter pylori. Nature 2007; 445: 915-8.
78. Hanahan D, Weinberg RA. The hallmark of cancer. Cell 2000; 100: 57-70.